Thyroid cancer
We activate antitumor immunity in thyroid cancer — gently and without severe toxic burden.
About the disease
Most forms of thyroid cancer respond well to surgery and radioiodine therapy, and the outlook for them is favorable. Problems begin with aggressive and rare forms - medullary and anaplastic cancer, as well as tumors that have stopped taking up radioiodine. Immunotherapy is meant for exactly these cases.
We train the patient's immune cells to recognize thyroid tumor cells and maintain long-term antitumor surveillance. This helps control the disease when standard methods are exhausted or give a weak response.
The method is used in recurrent, radioiodine-resistant, and aggressive forms, as well as in metastatic disease. Immunotherapy is used as part of comprehensive treatment, together with surgery and drug therapy.
The body's own cells work precisely, without a heavy toxic burden. The method combines with surgery and radioiodine therapy and does not interfere with them.
Immunotherapy is not prescribed to everyone. The physician assesses the tumor's histological type, radioiodine sensitivity, the pace of progression, and examination results. Only then is it clear whether the method is needed in a given situation.
For aggressive forms
Medullary and anaplastic cancer, where standard options are fewer.
When radioiodine stops working
Works when the tumor no longer takes up radioiodine.
Recurrence control
Long-term immune surveillance of remaining cells.
Combines with standard treatment
Does not interfere with surgery and radioiodine therapy.
Strict indication criteria
The method is not for everyone; the physician decides.
Extracorporeal immunotherapy
We move the immune 'training' process outside the body (ex vivo) — to an environment where we can create the conditions for training immunocompetent cells without creating any risk to your body.
Procedure
We draw your venous blood (up to 90 ml).
Activation (18 hours)
In the laboratory, using our proprietary technology (patents in Russia, the US, and the EU), we incubate the cells with immunomodulatory drugs and xenogeneic antigens. The cells receive a precise target.
Strike
We return the trained cells via subcutaneous injections. A powerful, multi-component immune response is developed.
Consolidation
The maintenance course forms long-term immunological memory, protecting against relapses for years.
Frequently asked questions
When is immunotherapy needed for thyroid cancer?
Most forms respond well to surgery and radioiodine. Immunotherapy is needed in aggressive, recurrent, and radioiodine-resistant forms, when standard methods give a weak response.
In which forms is the method especially appropriate?
In medullary and anaplastic cancer, in tumors that have lost the ability to take up radioiodine, and in metastatic disease. In these situations the options of standard treatment are more limited.
Can the method be combined with surgery and radioiodine therapy?
Yes. Immunotherapy complements standard treatment and does not interfere with it. It fits into the overall plan as part of a comprehensive approach.
How is the treatment tolerated?
Gently. The body's own cells do the work, so there is no heavy toxic burden and quality of life is preserved.
Is immunotherapy suitable for everyone?
No. The method is needed in complex and aggressive forms. The physician assesses the tumor type, radioiodine sensitivity, and pace of progression, and only then decides whether it is appropriate.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation with a review of records can be held remotely.
Other directions
Kidney cancer
Specific immune response against renal cell carcinoma without severe toxic burden.
Lung cancer
Comprehensive impact on the tumor while preserving healthy tissues across various forms of lung cancer.
Breast cancer
Forming long-term antitumor defense, reducing the risks of relapses and metastasis.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.